Utilization of Postoperative Chemoradiotherapy among Women in the United States with High-risk Cervical Cancer

Daniel Trifiletti, Samuel Swisher-McClure, Timothy N. Showalter, Leigh A. Cantrell, Surbhi Grover

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Objective: Prospective randomized data demonstrates that chemoradiotherapy (CRT) improves overall survival in women with high-risk pathologic features following radical hysterectomy. Despite this, not all high-risk patients receive adjuvant CRT and the patterns of care in this patient population are unknown. We sought to investigate the rates of adjuvant therapy utilization through analysis of the National Cancer Database. Materials and Methods: The National Cancer Database was queried for women with cervical cancer treated initially with hysterectomy from 2002 to 2012. Patients without high-risk pathologic features were excluded: pN +, positive surgical margins, and parametrial invasion (Peters' criteria). Among the 5947 evaluable patients, univariable analysis and multivariable analysis were performed to investigate potential factors associated with CRT utilization and overall survival following diagnosis. Results: Adjuvant CRT was performed in 41.8% of women and adjuvant radiotherapy, chemotherapy, and no adjuvant therapy was utilized in 9.8%, 23.6%, and 24.8% of women, respectively. On multivariable analysis, CRT utilization was associated with younger age, race, lower facility volume, pN +, parametrial invasion, and a negative surgical margin. Residence distance to treating facility, year of diagnosis, household income, insurance status, and facility type did not predict for CRT utilization. Conclusions: Despite level I evidence supporting its use, less than half of women in this large US cohort with high-risk cervical cancer received adjuvant CRT. Use of adjuvant CRT for women did not significantly increase between 2002 and 2012. Patient age, race, and pathologic risk factors were associated with use of adjuvant CRT.

Original languageEnglish (US)
Pages (from-to)452-457
Number of pages6
JournalAmerican Journal of Clinical Oncology: Cancer Clinical Trials
Volume41
Issue number5
DOIs
StatePublished - Jan 1 2018
Externally publishedYes

Fingerprint

Adjuvant Chemoradiotherapy
Chemoradiotherapy
Uterine Cervical Neoplasms
Hysterectomy
Databases
Adjuvant Radiotherapy
Insurance Coverage
Survival
Adjuvant Chemotherapy
Neoplasms
Patient Care
Therapeutics
Population

Keywords

  • cervical cancer
  • cervix
  • chemotherapy
  • hysterectomy
  • postoperative
  • radiation

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Utilization of Postoperative Chemoradiotherapy among Women in the United States with High-risk Cervical Cancer. / Trifiletti, Daniel; Swisher-McClure, Samuel; Showalter, Timothy N.; Cantrell, Leigh A.; Grover, Surbhi.

In: American Journal of Clinical Oncology: Cancer Clinical Trials, Vol. 41, No. 5, 01.01.2018, p. 452-457.

Research output: Contribution to journalArticle

Trifiletti, Daniel ; Swisher-McClure, Samuel ; Showalter, Timothy N. ; Cantrell, Leigh A. ; Grover, Surbhi. / Utilization of Postoperative Chemoradiotherapy among Women in the United States with High-risk Cervical Cancer. In: American Journal of Clinical Oncology: Cancer Clinical Trials. 2018 ; Vol. 41, No. 5. pp. 452-457.
@article{b465724e6be6412fb0b300b5c148b958,
title = "Utilization of Postoperative Chemoradiotherapy among Women in the United States with High-risk Cervical Cancer",
abstract = "Objective: Prospective randomized data demonstrates that chemoradiotherapy (CRT) improves overall survival in women with high-risk pathologic features following radical hysterectomy. Despite this, not all high-risk patients receive adjuvant CRT and the patterns of care in this patient population are unknown. We sought to investigate the rates of adjuvant therapy utilization through analysis of the National Cancer Database. Materials and Methods: The National Cancer Database was queried for women with cervical cancer treated initially with hysterectomy from 2002 to 2012. Patients without high-risk pathologic features were excluded: pN +, positive surgical margins, and parametrial invasion (Peters' criteria). Among the 5947 evaluable patients, univariable analysis and multivariable analysis were performed to investigate potential factors associated with CRT utilization and overall survival following diagnosis. Results: Adjuvant CRT was performed in 41.8{\%} of women and adjuvant radiotherapy, chemotherapy, and no adjuvant therapy was utilized in 9.8{\%}, 23.6{\%}, and 24.8{\%} of women, respectively. On multivariable analysis, CRT utilization was associated with younger age, race, lower facility volume, pN +, parametrial invasion, and a negative surgical margin. Residence distance to treating facility, year of diagnosis, household income, insurance status, and facility type did not predict for CRT utilization. Conclusions: Despite level I evidence supporting its use, less than half of women in this large US cohort with high-risk cervical cancer received adjuvant CRT. Use of adjuvant CRT for women did not significantly increase between 2002 and 2012. Patient age, race, and pathologic risk factors were associated with use of adjuvant CRT.",
keywords = "cervical cancer, cervix, chemotherapy, hysterectomy, postoperative, radiation",
author = "Daniel Trifiletti and Samuel Swisher-McClure and Showalter, {Timothy N.} and Cantrell, {Leigh A.} and Surbhi Grover",
year = "2018",
month = "1",
day = "1",
doi = "10.1097/COC.0000000000000309",
language = "English (US)",
volume = "41",
pages = "452--457",
journal = "American Journal of Clinical Oncology: Cancer Clinical Trials",
issn = "0277-3732",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Utilization of Postoperative Chemoradiotherapy among Women in the United States with High-risk Cervical Cancer

AU - Trifiletti, Daniel

AU - Swisher-McClure, Samuel

AU - Showalter, Timothy N.

AU - Cantrell, Leigh A.

AU - Grover, Surbhi

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Objective: Prospective randomized data demonstrates that chemoradiotherapy (CRT) improves overall survival in women with high-risk pathologic features following radical hysterectomy. Despite this, not all high-risk patients receive adjuvant CRT and the patterns of care in this patient population are unknown. We sought to investigate the rates of adjuvant therapy utilization through analysis of the National Cancer Database. Materials and Methods: The National Cancer Database was queried for women with cervical cancer treated initially with hysterectomy from 2002 to 2012. Patients without high-risk pathologic features were excluded: pN +, positive surgical margins, and parametrial invasion (Peters' criteria). Among the 5947 evaluable patients, univariable analysis and multivariable analysis were performed to investigate potential factors associated with CRT utilization and overall survival following diagnosis. Results: Adjuvant CRT was performed in 41.8% of women and adjuvant radiotherapy, chemotherapy, and no adjuvant therapy was utilized in 9.8%, 23.6%, and 24.8% of women, respectively. On multivariable analysis, CRT utilization was associated with younger age, race, lower facility volume, pN +, parametrial invasion, and a negative surgical margin. Residence distance to treating facility, year of diagnosis, household income, insurance status, and facility type did not predict for CRT utilization. Conclusions: Despite level I evidence supporting its use, less than half of women in this large US cohort with high-risk cervical cancer received adjuvant CRT. Use of adjuvant CRT for women did not significantly increase between 2002 and 2012. Patient age, race, and pathologic risk factors were associated with use of adjuvant CRT.

AB - Objective: Prospective randomized data demonstrates that chemoradiotherapy (CRT) improves overall survival in women with high-risk pathologic features following radical hysterectomy. Despite this, not all high-risk patients receive adjuvant CRT and the patterns of care in this patient population are unknown. We sought to investigate the rates of adjuvant therapy utilization through analysis of the National Cancer Database. Materials and Methods: The National Cancer Database was queried for women with cervical cancer treated initially with hysterectomy from 2002 to 2012. Patients without high-risk pathologic features were excluded: pN +, positive surgical margins, and parametrial invasion (Peters' criteria). Among the 5947 evaluable patients, univariable analysis and multivariable analysis were performed to investigate potential factors associated with CRT utilization and overall survival following diagnosis. Results: Adjuvant CRT was performed in 41.8% of women and adjuvant radiotherapy, chemotherapy, and no adjuvant therapy was utilized in 9.8%, 23.6%, and 24.8% of women, respectively. On multivariable analysis, CRT utilization was associated with younger age, race, lower facility volume, pN +, parametrial invasion, and a negative surgical margin. Residence distance to treating facility, year of diagnosis, household income, insurance status, and facility type did not predict for CRT utilization. Conclusions: Despite level I evidence supporting its use, less than half of women in this large US cohort with high-risk cervical cancer received adjuvant CRT. Use of adjuvant CRT for women did not significantly increase between 2002 and 2012. Patient age, race, and pathologic risk factors were associated with use of adjuvant CRT.

KW - cervical cancer

KW - cervix

KW - chemotherapy

KW - hysterectomy

KW - postoperative

KW - radiation

UR - http://www.scopus.com/inward/record.url?scp=84975481853&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84975481853&partnerID=8YFLogxK

U2 - 10.1097/COC.0000000000000309

DO - 10.1097/COC.0000000000000309

M3 - Article

C2 - 27322699

AN - SCOPUS:84975481853

VL - 41

SP - 452

EP - 457

JO - American Journal of Clinical Oncology: Cancer Clinical Trials

JF - American Journal of Clinical Oncology: Cancer Clinical Trials

SN - 0277-3732

IS - 5

ER -